Vasopressin and methylprednisolone for in-hospital cardiac arrest — Protocol for a randomized, double-blind, placebo-controlled trial

OBJECTIVE: To describe the clinical trial “Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest” (VAM-IHCA). METHODS: The VAM-IHCA trial is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of vasopressin and methylpr...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Lars W., Sindberg, Birthe, Holmberg, Mathias, Isbye, Dan, Kjærgaard, Jesper, Zwisler, Stine T., Darling, Søren, Larsen, Jacob Moesgaard, Rasmussen, Bodil S., Løfgren, Bo, Lauridsen, Kasper Glerup, Pælestik, Kim B., Sølling, Christoffer, Kjærgaard, Anders G., Due-Rasmussen, Dorte, Folke, Fredrik, Charlot, Mette Gitz, Iversen, Kasper, Schultz, Martin, Wiberg, Sebastian, Jepsen, Rikke Malene H.G., Kurth, Tobias, Donnino, Michael, Kirkegaard, Hans, Granfeldt, Asger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244400/
https://www.ncbi.nlm.nih.gov/pubmed/34223347
http://dx.doi.org/10.1016/j.resplu.2021.100081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244400/
https://www.ncbi.nlm.nih.gov/pubmed/34223347
http://dx.doi.org/10.1016/j.resplu.2021.100081

Ejemplares similares